Skip to main content
. 2025 May 8;15:100178. doi: 10.1016/j.obpill.2025.100178

Table 2.

Descriptive statistics: Gender, race, medication and HbA1c (%).

Variable Frequency Distribution
Gender
 Male 10 30 %
 Female 21 70 %
Race
 White 22 70 %
 AA 6 20 %
 Hispanic 3 10 %
Medication
 Tirzepatide 13 40 %
 Semaglutide 18 60 %
HbA1c (%) Mean 5.97 (95 % CI 5.9–6.1)Min 5.5, Max 6.7